Morgan Stanley Upgrades ResMed (RMD) to Overweight

FREE Breaking News Alerts from StreetInsider.com!

E-mail Address

StreetInsider.com Top Tickers, 10/23/2026

1. DECK
2. RNG
3. WDC
4. BYD
5. WCN
6. SPOT
7. BMY
8. SPY
9. FIX
10. TSCO

Go back to Morgan Stanley Upgrades ResMed (RMD) to Overweight

ResMed Inc. Announces Results for the Fourth Quarter and Fiscal Year 2015

July 30, 2015 4:06 PM EDT

SAN DIEGO, July 30, 2015 /PRNewswire/ -- ResMed Inc. (NYSE: RMD) today announced results for its quarter ended June 30, 2015.  Revenue for the quarter was $453.1 million, a 9 percent increase compared with the quarter ended June 30, 2014 (a 17 percent increase on a constant currency basis).  Net income was $87.5 million, consistent with the quarter ended June 30, 2014.  Diluted earnings per share for the quarter were $0.61, consistent with the quarter ended June 30, 2014. 

The results for the quarter ended June 30, 2015 were impacted by two non-recurring items: first, expenses of $5.0 million ($3.5 million, net of tax) associated with the field... More